Taking a Look at Ritalin

755 WordsFeb 26, 20183 Pages
Ritalin Each day, more and more children, young adults, and even adults are diagnosed with Attention Deficit Hyperactive Disorder, more commonly known as ADHD. According to the Center of Disease Control (CDC), 6.4 million Americans aged 4-17 have been diagnosed with ADHD since 2011, and this number is steadily growing. As one of the most common neurodevelopmental disorders in children, ADHD is often diagnosed in childhood and is a non curable, yet manageable, disease. The most common treatment of ADHD is through stimulant medication, such as Ritalin. Since the 1950s, Ritalin has aided in the treatment of hundreds of thousands of patients affected by ADHD, and is less commonly used to treat narcolepsy, depression and obesity. Ritalin is a central nervous system stimulant, and is effective by affecting chemicals in the brain and nerves that are contributed to ADHD symptoms. Specifically, it works as an enzyme toward the chemicals dopamine and noradrenaline in areas of the brain that play a part in controlling attention and behaviour. The original patent for this drug was held by CIBA but has been transferred to the Novartic Corporation. It became licensed in 1955 by the U.S. Food and and Drug Administration. According to studies and surveys conducted by the CDC, approximately 4.3 million ADHD affected patients are currently prescribed Ritalin. The New York Times has reported that sales of Ritalin have more than doubled between 2007 and 2012, from $4 billion to $9
Open Document